CDC20 and colorectal cancer: CDC20 has been implicated in colorectal cancer, and its expression levels are positively correlated with advanced clinical stages, metastasis, and decreased survival rates, highlighting its potential as a key biomarker for diagnosing and predicting the prognosis of the disease [42].